

Feb 3 (Reuters) - AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use version of lupus ther...


(Alliance News) - UK grocery sales rose in January while inflation eased, according to new data from Wordpanel by Numerator on Tuesday, as own label s...


(Sharecast News) - Analysts at RBC Capital Markets updated its Centrica estimates ahead of the firm's 2025 year-end results, lowering its numbers but ...


(Alliance News) - AG Barr reports revenue growth and buys soft drink brands Fentimans and Frobishers, while Filtronic expects to meet market expectati...


* Bank of England watching food prices closely * Own label products account for 52.2% of January sales * Tesco and Sainsbury's win market share * A...


(Sharecast News) - Plus500 said on Tuesday that it has entered the US retail prediction markets through the launch of event-based contracts on its US ...


(Sharecast News) - The US health regulator has rejected an application by AstraZeneca to launch a self-injectable version of its lupus treatment Saphn...


PARIS, Feb 3 (Reuters) - Europe's largest asset manager, Amundi, on Tuesday reported higher-than-expected net inflows in the fourth-quarter, and the ...


(Sharecast News) - Shares in AG Barr jumped on Tuesday after the Irn-Bru maker said it had bought soft drinks maker Fentimans and premium juice brand ...


(Sharecast News) - Budget carrier Wizz Air posted an 8.5% year‑on‑year rise in passenger numbers in January, carrying 5.35m travellers, wh...


PARIS, Feb 3 (Reuters) - Europe's largest asset manager, Amundi, on Tuesday reported higher-than-expected net inflows in the fourth-quarter, and the ...


MILAN, Jan 28 (Reuters) - A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for betting on the...


LONDON, Feb 2 (Reuters) - Northwest European gasoline refinery profit margins rebounded on Monday after a sharp drop last week, gaining $1.75 to a...


Feb 2 (Reuters) - The UK's FTSE 100 closed at a record high on Monday as investors piled into financials and defensive pharma stocks amid a global se...


(Sharecast News) - GSK is planning to cut as many as 350 jobs in research & development in the UK and US, it was announced on Monday.